InvestorsHub Logo
Followers 61
Posts 7553
Boards Moderated 2
Alias Born 02/10/2010

Re: None

Wednesday, 04/16/2014 9:19:14 AM

Wednesday, April 16, 2014 9:19:14 AM

Post# of 146291
IMO - the important piece of the PR - the award, while nice, doesn't do anything to move us forward:

In another news, the Company reported today that construction of its modern R&D Lab and cGMP Clinical Production facility in Shelton, CT, is nearing completion. The construction of the R&D Lab sections is nearly complete, and construction of the cGMP section is in the final stage. The Company anticipates completion of this total renovation of the facility by June, 2014. Thereafter the project will enter facility testing and validation phase. The Company reports that there have been certain weather related delays that have also affected delivery of certain special equipment.

The Company also reported that it is producing Injectable FluCide™, our most advanced drug candidate, at its existing facilities, in the large quantity needed for the Safety and Toxicology (“Tox Package”) study. The strong safety observed in preliminary safety studies resulted in requirement of a very large quantity for the Tox Package study. Notably, the drug candidate was found to be safe even at the maximum feasible dosage level in a small animal study. The Company reports that it has successfully scaled up the production of injectable FluCide at its current facility.



Now those are some pieces relatively useful information!

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News